Left main revascularization with optical coherence tomography in a young male with newly diagnosed homozygous familial hypercholesterolemia

      Abstract

      Familial hypercholesterolemia is the most common primary lipid disorder responsible for coronary artery disease. A 22-year-old male presented with history of accelerating angina and extensive xanthomatous lesions all over the body. Coronary angiography showed significant left main and left anterior descending artery disease. Optical coherence tomography (OCT) imaging revealed areas of lipid rich plaque with thin capped fibrous atheroma, and inflammatory cell infiltration. Area of maximum stenosis showed fibrous plaque with dense lipid pool. OCT in this patient clarified plaque characteristics and achieved optimal procedural results. There were only few case reports which described OCT findings in patients with familial hypercholesterolemia.
      <Learning objective: Undiagnosed familial hypercholesterolemia may present with life-threatening complications. The index case presented with critical left main disease. Intravascular imaging is necessary in patients with primary lipid disorders undergoing percutaneous coronary intervention, which characterizes plaque, the index case had densely lipid rich plaque with areas of inflammation. Characterizing plaque characteristics in patients with lipid disorders might have an impact on the management of these patients, which needs to be clarified in appropriately sized studies.>

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiology Cases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nordestgaard BG
        • Chapman MJ
        • Humphries SE
        • Ginsberg HN
        • Masana L
        • Descamps OS
        • Wiklund O
        • Hegele RA
        • Raal FJ
        • Defesche JC
        • Wiegman A
        • Santos RD
        • Watts GF
        • Parhofer KG
        • Hovingh GK
        • et al.
        Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
        Eur Heart J. 2013; 34: 3478-3490
        • Nanchen D
        • Gencer B
        • Muller O
        • Auer R
        • Aghlmandi S
        • Heg D
        • Klingenberg R
        • Räber L
        • Carballo D
        • Carballo S
        • Matter CM
        • Lüscher TF
        • Windecker S
        • Mach F
        • Rodondi N.
        Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes.
        Circulation. 2016; 134: 698-709
        • Benito-Vicente A
        • Uribe KB
        • Jebari S
        • Galicia-Garcia U
        • Ostolaza H
        • Martin C.
        Familial hypercholesterolemia: The most frequent cholesterol metabolism disorder caused disease.
        Int J Mol Sci. 2018; 19: 3426
        • Damgaard D
        • Larsen ML
        • Nissen PH
        • Jensen JM
        • Jensen HK
        • Soerensen VR
        • Jensen LG
        • Faergeman O.
        The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population.
        Atherosclerosis. 2005; 180: 155-160
        • Motozato K
        • Sueta D
        • Sakamoto K
        • Nagamatsu S
        • Yamashita T
        • Sato R
        • Mitsuse T
        • Kanemaru Y
        • Takaoka K
        • Fujisue K
        • Takashio S
        • Arima Y
        • Yamamoto E
        • Kaikita K
        • Tsujita K.
        A case of repetitive acute coronary syndrome in a patient with familial hypercholesterolemia.
        J Cardiol Cases. 2019; 20: 200-204
        • Liu Z
        • Peng J
        • Wang S
        • Jiang T
        • Zhang W
        • Zhang C
        • Chen Y
        • Meng K
        • Lin J.
        Percutaneous coronary intervention for a Chinese familial hypercholesterolemia homozygous under the guidance of optical coherence tomography.
        Atheroscler Suppl. 2019; 36: 19-23
        • Katamine M
        • Minami Y
        • Hashimoto T
        • Ako J.
        Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease.
        Pract Lab Med. 2021; 24: e00202
        • Matsuzaki M
        • Hiramori K
        • Imaizumi T
        • Kitabatake A
        • Hishida H
        • Nomura M
        • Fujii T
        • Sakuma I
        • Fukami K
        • Honda T
        • Ogawa H
        • Yamagishi M.
        Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART).
        J Am Coll Cardiol. 2002; 40: 220-227
        • Nazif TM
        • Kalra S
        • Ali ZA
        • Karmpaliotis D
        • Turner ME
        • Starc TJ
        • Cao Y
        • Marboe CC
        • Collins MB
        • Leon MB
        • Kirtane AJ.
        Percutaneous coronary intervention with bioresorbable scaffolds in a young child.
        JAMA Cardiol. 2017; 2: 430-434
        • Hoeg JM
        • Feuerstein IM
        • Tucker EE.
        Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia.
        Arterioscler Thromb. 1994; 14: 1066-1074